These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17508773)

  • 1. Virtual screening, molecular interaction field, molecular dynamics, docking, density functional, and ADMET properties of novel AChE inhibitors in Alzheimer's disease.
    da Silva CH; Carvalho I; Taft CA
    J Biomol Struct Dyn; 2007 Jun; 24(6):515-24. PubMed ID: 17508773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
    da Silva CH; Campo VL; Carvalho I; Taft CA
    J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
    Ambure P; Kar S; Roy K
    Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer's.
    Dhanjal JK; Sharma S; Grover A; Das A
    Biomed Pharmacother; 2015 Apr; 71():146-52. PubMed ID: 25960230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B; Singh N
    Bioorg Med Chem; 2012 Feb; 20(3):1175-80. PubMed ID: 22257528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer's Disease.
    Iman K; Mirza MU; Mazhar N; Vanmeert M; Irshad I; Kamal MA
    CNS Neurol Disord Drug Targets; 2018 Apr; 17(1):54-68. PubMed ID: 29336270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a novel acetylcholinesterase inhibitor by structure-based virtual screening techniques.
    Chen Y; Fang L; Peng S; Liao H; Lehmann J; Zhang Y
    Bioorg Med Chem Lett; 2012 May; 22(9):3181-7. PubMed ID: 22472693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity.
    da Silva VB; de Andrade P; Kawano DF; Morais PA; de Almeida JR; Carvalho I; Taft CA; da Silva CH
    Future Med Chem; 2011 Jun; 3(8):947-60. PubMed ID: 21707398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
    Son M; Park C; Rampogu S; Zeb A; Lee KW
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
    Pacheco G; Palacios-Esquivel R; Moss DE
    J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase.
    Girisha HR; Narendra Sharath Chandra JN; Boppana S; Malviya M; Sadashiva CT; Rangappa KS
    Eur J Med Chem; 2009 Oct; 44(10):4057-62. PubMed ID: 19493592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease.
    Lin HQ; Ho MT; Lau LS; Wong KK; Shaw PC; Wan DC
    Chem Biol Interact; 2008 Sep; 175(1-3):352-4. PubMed ID: 18573242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling.
    Bembenek SD; Keith JM; Letavic MA; Apodaca R; Barbier AJ; Dvorak L; Aluisio L; Miller KL; Lovenberg TW; Carruthers NI
    Bioorg Med Chem; 2008 Mar; 16(6):2968-73. PubMed ID: 18249544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic function and Alzheimer's disease.
    Giacobini E
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S1-5. PubMed ID: 12973744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations.
    Malik R; Choudhary BS; Srivastava S; Mehta P; Sharma M
    J Biomol Struct Dyn; 2017 Nov; 35(15):3268-3284. PubMed ID: 27782777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential therapeutic agents against Alzheimer's disease from natural sources.
    Park SY
    Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benchmarking docking and scoring protocol for the identification of potential acetylcholinesterase inhibitors.
    Zaheer-ul-Haq ; Halim SA; Uddin R; Madura JD
    J Mol Graph Model; 2010 Jun; 28(8):870-82. PubMed ID: 20447848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common SAR Derived from Linear and Non-linear QSAR Studies on AChE Inhibitors used in the Treatment of Alzheimer's Disease.
    Pulikkal BP; Marunnan SM; Bandaru S; Yadav M; Nayarisseri A; Sureshkumar S
    Curr Neuropharmacol; 2017 Nov; 15(8):1093-1099. PubMed ID: 27964704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of the pharmacophore model of acetylcholinesterase inhibitor.
    Zhu Y; Tong XY; Zhao Y; Chen H; Jiang FC
    Yao Xue Xue Bao; 2008 Mar; 43(3):267-76. PubMed ID: 18630262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterocyclic inhibitors of AChE acylation and peripheral sites.
    Bolognesi ML; Andrisano V; Bartolini M; Cavalli A; Minarini A; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
    Farmaco; 2005; 60(6-7):465-73. PubMed ID: 15878569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.